Skip to main content

Table 2 Factors associated with heart failure among patients on hemodialysis therapy

From: Prevalence and predictors of heart failure among patients on maintenance hemodialysis therapy at Muhimbili National Hospital in Tanzania: a cross-sectional study

Characteristic N Heart failure p Value
Present Absent
Age (years) 160 56.1 ± 11.4 51.8 ± 13.4 NS
% Male 160 70.6 69.2 NS
% Diabetes mellitus 160 58.8 41.3 NS
Pre-dialysis MAP (mmHg) 160 105 ± 12 107 ± 15 NS
Post-dialysis MAP (mmHg) 160 110 ± 10 106 ± 14 NS
Duration on HD (months) * 160 18 (9.5–39) 18 (7–28) NS
Urea reduction ratio (%) 160 71.8 ± 7.9 70.0 ± 11.7 NS
Body mass index (kg/m2) 160 21.9 ± 3.7 22.5 ± 4.0 NS
Serum albumin (g/dl) 160 3.69 ± 0.41 3.72 ± 0.49 NS
Total cholesterol (mg/dl) 160 138 ± 41 154 ± 39 NS
C-reactive protein (mg/l) * 103 22.4 (11.2–62) 15 (6.0–34) NS
Malnutrition inflammation score (MIS) * 160 10 (5–12.5) 5 (4–10) 0.04
Total leucocyte count (× 109/l) 160 4.7 ± 1.8 5.1 ± 2.3 NS
Hemoglobin (g/dl) 160 8.3 ± 2.2 9.4 ± 1.9 0.02
Serum transferrin (mg/dl) 160 171 ± 32 196 ± 51 NS
Serum ferritin (ng/ml)* 102 115 (74–243) 117 (54–275) NS
Erythropoietin resistance index, ERI (U/kg per g/dl) 120 25.4 ± 10.8 19.3 ± 8.0 0.01
  1. *Median (Interquartile range), NS not significant (p ≥ 0.05)